<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
Philadelphia, Pennsylvania–(Newsfile Corp. – June 23, 2021) – Berger Montague is investigating securities fraud allegations against Frequency Therapeutics, Inc. (“Frequency” or the “Company”) on behalf of investors who purchased Frequency securities (NASDAQ: FREQ) between November 16, 2020 and March 22, 2021 (the “Class Period”). If you purchased Frequency securities during the Class Period and are interested in learning more about Berger Montague’s investigation, please contact attorneys Andrew Abramowitz at aabramowitz@bm.net or (215) 875-3015, or Donnell…
...read full article on Newsfile Corp
